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The crux of development is that
different cells need to be instructed
to follow different developmental
decisions. This involves signalling
between cells so that each cell knows
what its neighbour is doing. The
Notch protein is pivotal for
communication between cells during
development and if Notch activity is
perturbed, a cell may no longer be
aware of which fate it should adopt.
One consequence of eliminating
Notch function is that embryos
develop with too many neural cells
because a whole cohort of cells
adopts their default option, which is
neural differentiation. Hence, Notch
and related genes were originally
described as ‘neurogenic’.
It subsequently became clear that
Notch encodes a transmembrane
receptor required for cell–cell
signalling in a wide variety of cell-fate
decisions in diverse animal species.
The processes requiring Notch
include somitogenesis, limb and
appendage development, lymphoid
lineage selection, as well as axon
pathfinding and dendritic sprouting.
Indeed, it is becoming difficult to
name a developmental process that
does not require Notch at some stage,
and some pleiotropic human diseases
and cancers involve aberrant Notch
activity. The core elements of the
pathway are the Notch receptor, its
transmembrane ligands and an
intracellular transducer, although
there is a host of other factors that also
influence the pathway. 
What does Notch do?
Notch is best known for the process
called ‘lateral inhibition’, where it
antagonises the activity of genes that
determine cell fate and can amplify
initially small differences between
neighbouring cells. The latter occurs
through feedback regulation of
receptor and/or ligand expression in
the receiving cell, such that the
amount of ligand is decreased and/or
the amount of receptor is increased.
Although it is often the inhibitory
nature of the pathway that is
emphasized, its real beauty lies in its
amplification capacity.
One conserved example of lateral
inhibition is the selection of neural
precursor cells. Proneural proteins,
which direct cells towards a neural
fate, are expressed in broad domains.
Subsequently the neural precursors
are selected from these domains
through a process that requires
Notch. One cell acquires more ligand
activity than its neighbours and so
activates Notch in the surrounding
cells, leading to the transcription of
some of the best-characterised Notch
targets, the so-called HES genes
(hairy and Enhancer of split related).
The HES proteins in turn antagonise
the proneural proteins, preventing
the cells from pursuing a neural fate.
It is possible that an initial random
difference between cells sets this in
motion, but in many cases it is likely
that other patterning information
affects this process by conferring
subtle differences in ligand levels or
activity between cells. This
difference is then amplified by
Notch signalling.
The Notch pathway operates in a
variety of different ways, not just in
lateral inhibition. A contrasting
example is lateral induction, as
exemplified by the development of
the Drosophila wing. Here, a narrow
domain of Notch activity is
established at the dorsal–ventral
boundary and behaves as an
organising centre to coordinate the
growth and patterning of the wing.
In the activation of Notch at the
dorsal–ventral boundary, dorsal cells
expressing the ligand Serrate signal
to ventral cells expressing the ligand
Delta. Hence, the cells must be able
both to send and to receive the signal
simultaneously. This process
involves Fringe, a putative glycosyl
transferase. Fringe influences the
interactions between Notch and its
ligands such that cells expressing
Serrate and Fringe can only respond
to cells that express Delta. Fringe
homologues have been identified in
a wide range of species and are
commonly expressed where there is
signalling at the boundaries between
two populations of cells — for
example, in the developing somites
and between the two sides of the
developing limb.
How does Notch work?
Notch proteins consist of a large
extracellular domain (ECD), a single
transmembrane segment and an
intracellular domain (ICD)
(Figure 1). The ECD consists
primarily of EGF-type (epidermal
growth factor) repeats, ranging from
36 repeats in Drosophila Notch and
vertebrate Notch-1, to 10 repeats in
the Caenorhabditis elegans homologue,
GLP-1. Six contiguous ankyrin
repeats within the ICD form the
docking site for several cytoplasmic
factors that regulate Notch activity
(for example, Deltex in Drosophila
and EMB-5 in C. elegans). Other
proteins involved in transducing and
modulating Notch activity bind to
regions of ICD that flank the ankyrin
repeats (Figure 2).
During export to the cell surface,
Notch is processed (known as S1
cleavage) by a furin protease. This
cleaves the ECD, which remains
linked to the transmembrane domain
and ICD by a Ca2+-sensitive
interaction in the mature Notch
molecule. Activation of Notch is
accompanied by two further cleavage
events (Figure 1). The S2 cleavage
also occurs in the extracellular part of
the protein, and severs the ECD.
The final S3 cleavage occurs on the
intracellular side of the
transmembrane domain and releases
the ICD to form a cleavage product
known as Nicd. Engineered forms of
Notch that resemble Nicd behave
like constitutively activated Notch
receptors in cell culture and in
transgenic experiments. Hence, it
seems that ligand binding causes a
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conformational change in the protein
that allows the S2 and S3 activating
cleavages to occur, releasing Nicd. 
In C. elegans the product of sel12, a
homologue of presenilin 1, is a
candidate for regulating Notch. As
presenilins are involved in processing
the b -amyloid precursor protein, it
seemed possible that they could
participate in Notch cleavage.
Indeed, genetic and molecular
studies support the g -secretase
associated with presenilins as a
candidate for the S3 cleavage. There
are a few cases where the correlation
between presenilin activity, Notch
processing and Notch activity are not
fully congruent, so there may yet be
more to discover in this process.
Notch signalling
DNA-binding proteins of the CSL
family are central to the intracellular
transduction of the Notch signal.
CSL family members include
CBF/RBPkJ in mammals, Suppressor
of Hairless in Drosophila and LAG-1
in C. elegans. CSL proteins bind to
the enhancer regions of Notch target
genes, and their binding sites are
necessary for the activity of these
genes. CSL proteins also interact
directly with the RAM23 part of the
intracellular domain of Notch. There
is still some debate, however, about
the precise mechanisms by which
Nicd ‘activates’ CSL.
One model for Notch regulation
of CSL function is that Nicd interacts
with CSL in the nucleus and converts
it from a transcriptional repressor to
an activator. Studies on CSL in
mammalian cells have shown that it
can repress transcription and bind
directly to a co-repressor complex
containing a histone deacetylase. Nicd
and the co-repressor complex interact
with the same region of CSL. Nicd
seems to contain a sequence that
targets it to the nucleus, and once
there it may displace or replace the
co-repressor complex and recruit an
activation complex to CSL.
An alternative model is that Notch
activation promotes translocation of
CSL into the nucleus (where Nicd
may still be required as a co-activator;
see Figure 1). When Notch is on the
surface of a cell, a significant
proportion of CSL tends to be
retained in the cytoplasm, and in the
presence of Nicd more CSL is found
in the nucleus. But CSL distribution
in vivo does not correlate particularly
well with Notch activity, suggesting
that translocation is insufficient to
explain Notch signal transduction.
Whatever the basic mechanism,
we need to understand more precisely
how and where Nicd makes a complex
with CSL to activate transcription of
target genes. Different target genes
are activated in different contexts —
depending on the other transcription
factors present — and govern
whether Notch signalling inhibits
specific cell fates (as in neurogenesis)
or elicits cell proliferation (as in the
Drosophila wing).
The HES gene paradigm
originates from Drosophila where
expression of the Enhancer of split
family of genes was shown to be
dependent on Notch activity. These
genes contain binding sites for CSL
and are direct transcriptional targets
whose expression provides an
indicator of Notch activity in many
processes, including neurogenesis.
Another well-characterised target
gene from Drosophila is vestigial.
This, too, contains a CSL-binding
site and responds to Notch activity,
specifically in the developing
wing and eye during one
developmental phase.
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Figure 1
(a) The Notch receptor (in Drosophila). The
mature receptor consists of two fragments.
The ECD contains 36 EGF repeats (dark
blue; EGF repeats 11 and12, red) and three
Notch/LIN-12 repeats (light blue). The ECD
is linked non-covalently to the transmembrane
domain and ICD. The central portion of the
ICD contains six ankyrin repeats (orange).
(b) Model for events accompanying Notch
activation. A ligand (green) and Notch
receptor (blue) on two opposing cells
interact. The extracellular domain of the ligand
contains many EGF repeats (green) and the
amino-terminal residues form a domain (DSL;
pink) that is essential for interactions with the
Notch receptor. Interactions between the
ligand and Notch are thought to cause a
conformational change that exposes a
proteolytic site, S2. Cleavage at S2 allows a
second cleavage, S3, which releases the
product Nicd. (c) The cleaved Nicd can enter
the nucleus, either unaided or through
interactions with CSL (light blue). The
promoter regions of the genes that Notch
binds to might be kept inactive by bound
CSL that recruits a co-repressor complex
(yellow). In the nucleus, Nicd might both
dissociate the repressor complex and
recruit/contribute co-activators so that
transcription of target genes is initiated.
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Although CSL proteins are the
only well-characterised transducers of
Notch activity, other transduction
mechanisms may exist. As Notch
activity affects cell morphology (for
example, axon pathfinding ability in
Drosophila and dendrite outgrowth in
mammalian neural cells) as well as
cell fates, it would make sense if there
were an alternative transduction route
that did not involve changes in
transcription. One candidate from
Drosophila is Disabled, which can
interact directly with Nicd and with
the Abl protein kinase.
Notch activation
The ligands for the Notch receptor
are transmembrane proteins, which
contain many EGF repeats in their
extracellular domain, and have some
similarity to Notch itself. They are
collectively known as DSL (for
Delta, Serrate and LAG-2) proteins,
and broadly fall into three groups
according to the number of repeats
they possess. Exactly how the
interaction between the DSL ligands
and Notch results in activation is still
unclear. The process requires the
amino-terminal domain of the
ligands, as well as the EGF repeats
10 and 11 in the Notch ECD. The
specificity of ligand interactions is
also affected by Fringe, which blocks
the ability of Serrate to activate
Notch. There are hints that different
EGF repeats within Notch mediate
the specificity of ligand interactions.
In Drosophila there is only one
Delta and one Serrate ligand;
mammals, however, have several
different Delta-like and Serrate-like
ligands, as well as four Notch
receptors. This opens up the
possibility of preferential interactions
between specific classes of ligand and
Notch receptors. Some evidence
suggests that the Notch3 receptor
could be an inhibitor, acting in
opposition to other Notch receptors.
Further characterization of the
vertebrate proteins is necessary to
distinguish any unique activities.
Other interacting proteins
There are various other proteins that
interact with Notch (Figure 2). Some
of these, such as SKIP and the
C. elegans proteins EMB-5 and LAG-3,
seem to mediate the effects of Nicd on
transcription. Other interacting
proteins, such as Dishevelled and
Numb, represent mechanisms for
intracellular regulation of Notch
activity. Although many of these
interactions are, as yet, ill defined,
they are likely to provide important
routes through which other signalling
pathways can interact with Notch.
Numb is a well-characterised
negative regulator of Notch that
functions during asymmetrical
cleavage divisions, for example, in the
lineage of sensory organ precursor
cells. The Numb protein, which is
localized to the cortex of the precursor
cell, becomes asymmetrically
distributed during cell division. All the
Numb is therefore inherited by only
one daughter cell, where it binds to
the intracellular domain of Notch and
inhibits activity. It will be interesting
to see whether the subcellular
localizations of other interacting
proteins, such as Dishevelled or
Deltex, are also important for
controlling exactly where in the cell
Notch can be activated.
Future directions
We now have a simple model for the
Notch signalling pathway, but there
are still many unanswered questions
about how the pathway operates —
even at the core level. Furthermore,
it is rapidly becoming apparent that
many different events require
Notch. We need to discover what
Notch is doing in these different
places and whether the Notch
pathway is linear, or whether there
are different routes by which Notch
influences cell behaviours.
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Figure 2
Summary of the different interacting proteins that may mediate or modulate Notch activity.
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Protein
Fringe
Numb
Disabled
CSL 
LAG-3
Deltex
SKIP
EMB-5
Dsh
Function
? Glycosyl transferase
Boundaries: wing, eye, leg
Somitogenesis,
limb development
Asymmetrical, cytoskeleton-
associated, antagonises Notch
Axon pathfinding
Transcription factor in
most/all Notch responses
In complex with CSL proteins,
? transcriptional activator.
Cytoplasmic protein,
modulates Notch
In complex with CSL proteins
+ve regulator, ? affects chromatin
?–ve regulator, mechanism for
Wnt modulation of Notch  
Species
Drosophila [Fringe],
Chick, mouse
[Lunatic Fringe,
Radical Fringe,
Manic Fringe]
Drosophila,
mouse, rat, human
Drosophila
Mouse, rat, human [CBF]
Drosophila [Su(H)]
C. elegans [LAG-1]
C. elegans
Drosophila, human
Human, C. elegans, 
Drosophila
C. elegans
Drosophila
C
EGF repeats 22-36
Notch/LIN-12
repeats
